Stephen Mandel's Lone Pine Capital significantly increased its position in medical supply company Medline Inc. (MDLN), according to a recent quarterly disclosure. The fund added approximately 9.18 million shares, bringing its total to 20.97 million. This represents a 77.86% increase in their holding during the second quarter of 2026, which concluded on June 30. The total reported value of Lone Pine's stake in Medline now stands at about $827 million, making up 5.06% of their reported portfolio.
Investors should note that this information is from a delayed 13F filing, which reflects positions held at the end of the previous quarter and not necessarily current holdings. The increased investment occurred during a quarter where Medline announced plans to open two large new distribution centers in Northern California. [4] However, the company also received an FDA warning letter in early June regarding manufacturing practices, which led to a temporary drop in its stock price. [5]